27.9 C
Friday, January 15, 2021
- Advertisement -

In Talks with Big Pharma, Osinbajo Requests Priority for Nigeria Once Coronavirus Vaccine is Developed


2020: A Year Like no Other By Dakuku Peterside

The year 2020 was supposed to be a great year. It was another Leap Year – the famed Olympic Games year when...

The Time to Restructure is Now – Bola Tinubu

Being with you at this special event today, I am visited by two competing emotions. I continue to feel a profound sense...

Africa and the COVID-19 Vaccine – By Dakuku Peterside

The year 2020 will forever be synonymous with Covid-19, a pandemic that brought the world to her knees. For the first time...

Buhari is Repressing Human Rights and Getting Away With It – By Kolawole Olaniyan

President Muhammadu Buhari is failing to live up to his promises to ensure respect for human rights, obey the rule of law,...

Nigeria’s Vice President Yemi Osinbajo said during a virtual meeting with senior government officials and representatives of Big Pharma that the Buhari administration intends to examine every possible option in the development and distribution of a vaccine against the COVID-19 coronavirus, and that the health and safety of Nigerian citizens remains the government’s priority.

Mr Osinbajo said this during a meeting with representatives of the BNT162 COVID-19 vaccine candidate on the progress of the development of the vaccine. The meeting had in attendance Health Minister, Osagie Ehanire, the Executive Director of the National Primary Health Care Development Agency, Faisal Shuaib and representatives of Pfizer and Biotech, the international pharmaceutical firms promoting the BNT162 vaccine candidate.

Mr Osinbajo said the interaction between the Nigerian government and the promoters of the vaccine candidate “is an important conversation and it is important for us that we are prioritized-as the largest country in Africa-in the distribution of the best COVID-19 vaccine when it is eventually ready.

“Our priority is the health of the Nigerian citizens. We continue to engage and intend to look at every possible option -from all manufacturers- of a good vaccine. We want to do the very best for our people in this regard.”

The Vice President asked several questions about the COVID-19 vaccine candidate during the meeting, including how quickly can Nigeria get the vaccine once it becomes available.

Mr Olayinka Subair, Pfizer’s Country Manager and Representative in Africa, who spoke on behalf of the promoters, said that “Nigeria will be a priority.” Although the vaccine is not currently being tested in Nigeria, he said the trails are ongoing in parts of the African continent and would be entering the third phase after two successful phases.

- Advertisement -
- Advertisement -

Business Profiles

Ngozi Edozien

Ngozi Edozien is the founder and Managing Director of Invivo Partners Limited. She has over 20 years’ experience in finance/private equity, general...

Sanyade Okoli

Sanyade Okoli is Chief Executive Officer at Alpha African Advisory. She has over 21 years of financial advisory, private equity, corporate, commercial...

Samuel Nwanze

Samuel Nwanze is a director of Transcorp Power. He holds an MSc. degree in Finance and Management from Cranfield University in the...

Olukemi Adeniji

Ms Adeniji has a law degree and a Masters in International Law and Diplomacy (M.I.L.D) from the University of Lagos. She has...

Chikezie Nwosu

Chikezie Nwosu is an experienced senior executive with over 29 years local and international experience in the oil & gas industry vis-a-viz...